- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.08. | CapsoVision stock rating maintained at Speculative Buy by Benchmark | 1 | Investing.com | ||
| 14.08. | CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission | 1 | Seeking Alpha | ||
| 13.08. | CapsoVision Q2 2026 Earnings Call Transcript | 1 | Benzinga.com | ||
| 13.08. | CapsoVision, Inc - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 03.08. | CapsoVision launches AI feature for capsule endoscopy abroad | 3 | Investing.com | ||
| 03.08. | CapsoVision Announces International Launch of AI Highlights | 383 | GlobeNewswire (Europe) | AI-assisted review feature designed to support physician review of small bowel capsule endoscopy studies using the CapsoCam Plus systemSARATOGA, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision... ► Artikel lesen | |
| CAPSOVISION Aktie jetzt für 0€ handeln | |||||
| 02.07. | CapsoVision beruft Gastroenterologen David Shields in den Verwaltungsrat | 4 | Investing.com Deutsch | ||
| 02.07. | CapsoVision appoints gastroenterologist David Shields to board | 1 | Investing.com | ||
| 02.07. | CapsoVision, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 02.07. | CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors | 133 | GlobeNewswire (Europe) | SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions... ► Artikel lesen | |
| 12.06. | CapsoVision: Aktionäre bestätigen Direktoren und Wirtschaftsprüfer auf Jahreshauptversammlung | 2 | Investing.com Deutsch | ||
| 12.06. | CapsoVision, Inc - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | Benchmark reiterates Speculative Buy on CapsoVision stock at $10 | 1 | Investing.com | ||
| 15.05. | CapsoVision expects AI-assisted reading clearance around midyear, with CapsoCam Colon Gen 2 imaging and AI module targeted for Q3 2026 | 6 | Seeking Alpha | ||
| 14.05. | Transcript: CapsoVision Q1 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| 14.05. | CapsoVision, Inc. GAAP EPS of -$0.15 misses by $0.02, revenue of $2.8M misses by $0.18M | 1 | Seeking Alpha | ||
| 14.05. | CapsoVision, Inc - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.05. | CapsoVision, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 30.04. | CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 | 1 | GlobeNewswire (USA) | ||
| 17.04. | CapsoVision, Inc - S-1, General form for registration of securities | - | SEC Filings |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 46,600 | +0,83 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 49,750 | 0,00 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| LIFESTANCE HEALTH GROUP | 12,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,170 | +0,08 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| PROGYNY | 25,650 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,84 | -0,05 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 95,20 | +0,18 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,480 | +1,06 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| GENEDX | 87,05 | 0,00 % | GeneDx launches online exome testing for pediatric patients | ||
| ALIGNMENT HEALTHCARE | 13,165 | +0,04 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| SANARA MEDTECH | 34,430 | -0,06 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,120 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,670 | -0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
CAPSOVISION INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,180 (-3,61 %) liegt der Kurs bei 4,800 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAPSOVISION INC finden Sie auf Wallstreet Online.